{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:44:04Z","timestamp":1780940644139,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.etap.2014.05.012","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T04:30:31Z","timestamp":1401337831000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Environmental risk assessment of selected pharmaceuticals in Turkey"],"prefix":"10.1016","volume":"38","author":[{"given":"Merve","family":"O\u011fuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdi","family":"Mih\u00e7iokur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2014.05.012_bib0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.scitotenv.2008.04.028","article-title":"A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States Groundwater","volume":"402","author":"Barnes","year":"2008","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.etap.2014.05.012_bib0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/qsar.200390030","article-title":"Pharmaceuticals and personal care products in the environment: regulatory drivers and research needs","volume":"22","author":"Boxall","year":"2003","journal-title":"QSAR and Combinational Science"},{"key":"10.1016\/j.etap.2014.05.012_bib0015","series-title":"The Lost Language of Plants the Ecological Importance of Plant Medicines to Life on Earth","author":"Buhner","year":"2002"},{"key":"10.1016\/j.etap.2014.05.012_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.scitotenv.2008.06.038","article-title":"Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of HanRiver, Korea","volume":"405","author":"Choi","year":"2008","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.etap.2014.05.012_bib0025","unstructured":"DLEM (Department of Local Environmental Management), 2006. Initial assessment of eleven pharmaceuticals using the EMEA guideline in Norway."},{"key":"10.1016\/j.etap.2014.05.012_bib0030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/es00067a004","article-title":"Sorption of toxic organic compounds on wastewater solids: correlation with fundamental properties","volume":"23","author":"Dobbs","year":"1989","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.etap.2014.05.012_bib0035","series-title":"EU Ad Hoc Working party, III\/5504\/94 Draft 4","article-title":"Assessment of potential risks to the environment posed by medicinal products for human use, excluding products containing live genetically modified organisms","author":"EC (European Commission)","year":"1994"},{"key":"10.1016\/j.etap.2014.05.012_bib0040","series-title":"Pharmaceuticals in the Environment: Current Knowledge and Need Assessment to Reduce Presence and Impact","author":"EC (European Commission)","year":"2010"},{"key":"10.1016\/j.etap.2014.05.012_bib0045","series-title":"Water Reclamation technologies for safe managed aquifer recharge","author":"EC (European Commission)","year":"2012"},{"key":"10.1016\/j.etap.2014.05.012_bib0050","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1021\/ac030224a","article-title":"Solid-phase extraction of amphiphiles based on mixed hemimicelle\/admicelle formation: application to the concentration of benzalkonium surfactants in sewage and river water","volume":"75","author":"Francisco","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.etap.2014.05.012_bib0055","unstructured":"GACE (German Advisory Council on the Environment), 2007. Pharmaceuticals in the environment."},{"key":"10.1016\/j.etap.2014.05.012_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.chroma.2012.12.072","article-title":"Rapid analysis of multiclass antibiotic residues and some of their metabolites in hospital, urban wastewater and river water by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry","volume":"1292","author":"Gros","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.etap.2014.05.012_bib0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ecoenv.2007.10.015","article-title":"Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline","volume":"71","author":"Grung","year":"2008","journal-title":"Ecotoxicol. Environ. Safety"},{"key":"10.1016\/j.etap.2014.05.012_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/46.suppl_1.53","article-title":"Environmental risk assessment of antibiotic: comparison of mecillinam, trimethoprim and ciprofloxacin","volume":"46","author":"Halling-Sorensen","year":"2000","journal-title":"J. Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1016\/j.etap.2014.05.012_bib0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0045-6535(97)00354-8","article-title":"Occurrence, fate, and effects of pharmaceutical substances in the environment","volume":"36","author":"Halling-Sorensen","year":"1998","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.etap.2014.05.012_bib0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/etc.5620170305","article-title":"Identification of fluoroquinolone antibiotics as the main source of UmuC genotoxicity in native hospital wastewater","volume":"17","author":"Hartmann","year":"1998","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.etap.2014.05.012_bib0085","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00216-006-0394-5","article-title":"Trace-level determination of pharmaceuticals residues by LC\u2013MS\/MS in natural and treated waters. A pilot Survey Study","volume":"385","author":"Hernando","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"issue":"1\u20132","key":"10.1016\/j.etap.2014.05.012_bib0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0048-9697(98)00337-4","article-title":"Occurrence of antibiotics in the aquatic environment","volume":"225","author":"Hirsch","year":"1999","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.etap.2014.05.012_bib0095","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/S0043-1354(02)00227-0","article-title":"Aquatic environmental assessment of the top 25 English prescription pharmaceuticals","volume":"36","author":"Jones","year":"2002","journal-title":"Water Res."},{"key":"10.1016\/j.etap.2014.05.012_bib0100","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.envpol.2005.08.077","article-title":"The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment","volume":"145","author":"Jones","year":"2007","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.etap.2014.05.012_bib0105","series-title":"Proceedings of the 12th International Conference on Environmental Science and Technology","article-title":"Estimation of potential environmental risks associated with human antibiotic consumption in two regions of Greece","author":"Latrou","year":"2011"},{"key":"10.1016\/j.etap.2014.05.012_bib0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.chroma.2005.07.070","article-title":"Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid phase extraction and gas chromatography-mass spectrometry","volume":"1094","author":"Lee","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.etap.2014.05.012_bib0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.chroma.2006.11.068","article-title":"Determination of Ofloxacin, Norfloxacin, and Ciprofloxacin in sewage by selective solid phase extraction liquid chromatography with fluorescence detection, and liquid chromatography\u2013tandem mass spectrometry","volume":"1139","author":"Lee","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.etap.2014.05.012_bib0120","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.scitotenv.2009.03.009","article-title":"Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical product ion facilities","volume":"407","author":"Lin","year":"2003","journal-title":"Sci. Total Environ."},{"issue":"11","key":"10.1016\/j.etap.2014.05.012_bib0125","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0043-1354(97)00121-8","article-title":"Biodegradability of the antitumor agent ifosfamide and its occurrence in hospital effluents and communal sewage","volume":"3","author":"Kummerer","year":"1997","journal-title":"Water Res."},{"key":"10.1016\/j.etap.2014.05.012_bib0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0045-6535(99)00439-7","article-title":"Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test","volume":"40","author":"Kummerer","year":"2000","journal-title":"Chemosphere"},{"issue":"6\u20137","key":"10.1016\/j.etap.2014.05.012_bib0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0045-6535(01)00144-8","article-title":"Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources","volume":"45","author":"Kummerer","year":"2001","journal-title":"Chemosphere"},{"key":"10.1016\/j.etap.2014.05.012_bib0140","series-title":"Pharmaceuticals in the Environment: Sources, Fate Effects and Risks","author":"Kummerer","year":"2004"},{"key":"10.1016\/j.etap.2014.05.012_bib0145","first-page":"189","article-title":"Bioconcentration and biomagnification in the aquatic environment","author":"Morrison","year":"2000","journal-title":"Environ. Health Sci."},{"key":"10.1016\/j.etap.2014.05.012_bib0150","series-title":"Organic pollutants in the water cycle: properties, occurrence, analysis and environmental relevance of polar compounds","author":"Remtsma","year":"2006"},{"issue":"B","key":"10.1016\/j.etap.2014.05.012_bib0155","first-page":"229","article-title":"consumption and environmental hazards of pharmaceutical substances in the UK","volume":"81","author":"Sebastine","year":"2003","journal-title":"Trans I Chem E"},{"key":"10.1016\/j.etap.2014.05.012_bib0160","unstructured":"Stockholm County Council (2012) Environmentally classified pharmaceuticals report."},{"issue":"7","key":"10.1016\/j.etap.2014.05.012_bib0165","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0045-6535(99)00453-1","article-title":"Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use","volume":"40","author":"Stuer-Lauridsen","year":"2000","journal-title":"Chemosphere"},{"key":"10.1016\/j.etap.2014.05.012_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0048-9697(98)00339-8","article-title":"Polar drug residue in sewage and natural waters in the State of Rio de Janeiro, Brazil","volume":"225","author":"Stumpf","year":"1999","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.etap.2014.05.012_bib0175","unstructured":"TSIa (Turkish Statistical Institutea), 2013. http:\/\/www.tuik.gov.tr\/PreHaberBultenleri.do?id=13425."},{"key":"10.1016\/j.etap.2014.05.012_bib0180","unstructured":"TSIb (Turkish Statistical Instituteb), 2013. http:\/\/tuikapp.tuik.gov.tr\/cevredagitimapp\/belediyeatiksu.zul."},{"key":"10.1016\/j.etap.2014.05.012_bib0185","series-title":"Drug industry specialization commission report ninth development plan (2007-2013). Ankara","author":"T.S.P.O. (Turkey State Planning Organization)","year":"2006"},{"key":"10.1016\/j.etap.2014.05.012_bib0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhazmat.2008.11.012","article-title":"Appraisal of potential environmental risks associated with human antibiotic consumption in Turkey","volume":"166","author":"Turkdogan","year":"2009","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.etap.2014.05.012_bib0195","series-title":"Estimation Program Interface EPI; Suite, version 3.10","author":"US EPA (US Environmental Protection Agency)","year":"2001"},{"key":"10.1016\/j.etap.2014.05.012_bib0200","series-title":"Proceedings of the International Seminar on Pharmaceuticals in the Environment","article-title":"Risk assessment approaches for pharmaceuticals","author":"Webb","year":"2000"}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668914001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668914001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:24:29Z","timestamp":1538598269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668914001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1382668914001276"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2014.05.012","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental risk assessment of selected pharmaceuticals in Turkey","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2014.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}